COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021
- COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors
- These agreements mean that all COVAX’s 190 participating and eligible economies will be able to access doses to protect vulnerable groups in the first half of 2021. At least 1.3 billion donor-funded doses will be made available to 92 economies eligible for the Gavi COVAX AMC, targeting up to 20% population coverage by the end of the year.
- Funding raised in 2020 and early pledges toward 2021 targets, alongside these agreements, offer clearest pathway yet to ending the acute phase of the pandemic globally by the end of 2021
Geneva/Oslo, 18 December 2020 – COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income level, today announced that it had arrangements in place to access nearly two billion doses of COVID-19 vaccine candidates, on behalf of 190 participating economies. For the vast majority of these deals, COVAX has guaranteed access to a portion of the first wave of production, followed by volume scales as further supply …continued .
[Original Source: WHO]